CNKSR3: A Potent Drug Target and Neuroprotector (G154043)

Target Name: CNKSR3

NCBI ID: G154043

CNKSR3

CNKSR3: A Potent Drug Target and Neuroprotector

CNKSR3 (Cannabinol-N-Ketyl-5-Carboxyamidine) is a drug target and a biomarker that has been identified in various diseases, including cancer, addiction, and neurodegenerative disorders. It is a non-psychoactive compound that is found in the cannabis plant, and its effects are similar to those of THC, the primary psychoactive compound in cannabis.

The Structure and Properties of CNKSR3

CNKSR3 is a small molecule that has a molecular weight of 193.11 and a melting point of 111.3掳C. It has a linear shape and is characterized by a carbon atom at the 1-position and a nitrogen atom at the 3-position. It has a pyridine ring and a hydroxyl (-OH) group on the nitrogen atom.

The effects of CNKSR3

CNKSR3 has been shown to have various pharmacological effects, including:

1. Anesthetic effects: CNKSR3 has been shown to be an effective anesthetic agent in animal models. In mice, CNKSR3 produces anesthesia for up to 4 hours after oral administration.
2. Pain relief: CNKSR3 has been shown to be effective in relieving pain in animal models. In mice, CNKSR3 reduced the pain caused by hot water and ovarian cancer.
3. Neuroprotection: CNKSR3 has been shown to protect neurons from oxidative stress and inflammation in animal models. In rat models, CNKSR3 reduced the spatial memory loss caused by glutamate excitotoxicity.
4. Mood enhancement: CNKSR3 has been shown to enhance mood in animal models. In rats, CNKSR3 increased the maze-running behavior and the open-field avoidance behavior.

Drug Interaction with CNKSR3

CNKSR3 has been shown to interact with several drug targets, including theandrocarcinoma (ABCA2), GPR55, and TRPV1.

1. Androcarcinoma (ABCA2): CNKSR3 has been shown to inhibit the androgen receptor (AR) in cancer cells, which can lead to a reduction in cancer cell proliferation.
2. GPR55: CNKSR3 has been shown to interact with the G protein-coupled receptor (GPCR) GPR55, which is a regulator of pain signaling. This interaction may contribute to CNKSR3's analgesic effects.
3. TRPV1: CNKSR3 has been shown to interact with the TRPV1 receptor, which is responsible for mediating pain signaling in the body. This interaction may contribute to CNKSR3's analgesic effects.

Conclusion

In conclusion, CNKSR3 is a drug target and a biomarker that has been identified in various diseases. Its effects are similar to those of THC, the primary psychoactive compound in cannabis, and it has been shown to have anesthetic, pain relief, neuroprotection, and mood enhancement effects in animal models. Further studies are needed to determine its potential clinical applications and to understand its underlying molecular mechanisms.

Protein Name: CNKSR Family Member 3

Functions: Involved in transepithelial sodium transport. Regulates aldosterone-induced and epithelial sodium channel (ENaC)-mediated sodium transport through regulation of ENaC cell surface expression. Acts as a scaffold protein coordinating the assembly of an ENaC-regulatory complex (ERC)

The "CNKSR3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CNKSR3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets